| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| Q9BY79 (MFRP_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Membrane frizzled-related protein; Membrane-type frizzled-related protein; | |
| A0A0J9YX94 (PMA6F_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Paraneoplastic antigen Ma6F; | |
| Q8NDW4 (ZN248_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 248; | |
| Q8WVR3 (TPC14_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Trafficking protein particle complex subunit 14; Microtubule-associated protein 11; | |
| Q9H930 (SP14L_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Nuclear body protein SP140-like protein; | |
| O75426 (FBX24_HUMAN) | Swiss-Prot | Homo sapiens (Human) | F-box only protein 24; | |
| Q9NXV6 (CARF_HUMAN) | Swiss-Prot | Homo sapiens (Human) | CDKN2A-interacting protein; Collaborator of ARF; | |
| Q86SG3 (DAZ4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Deleted in azoospermia protein 4; | |
| O00634 (NET3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Netrin-3; Netrin-2-like protein; | |
| P0C7M7 (ACSM4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Acyl-coenzyme A synthetase ACSM4, mitochondrial; Acyl-CoA synthetase medium-chain family member 4; | |
| Q3MIX3 (ADCK5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Uncharacterized aarF domain-containing protein kinase 5; | |
| Q7Z5A8 (TAFA3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Chemokine-like protein TAFA-3; | |
| C9JQL5 (DSA2D_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative dispanin subfamily A member 2d; | |
| P61366 (OSTN_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Osteocrin; Musclin; Processed Osteocrin; | |
| Q7Z5A9 (TAFA1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Chemokine-like protein TAFA-1; | |
| Q6F5E7 (TR3N_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein TXNRD3NB; Thioredoxin reductase 2 intronic transcript 1; Thioredoxin reductase 3 intronic transcript 1; Thioredoxin reductase 3 neighbor gene protein; Thioredoxin reductase 3 new transcript 1; | |
| Q02575 (HEN1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Helix-loop-helix protein 1; Class A basic helix-loop-helix protein 35; Nescient helix loop helix 1; | |
| Q8TEF2 (CJ105_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Uncharacterized protein C10orf105; | |
| Q658K8 (EF1DL_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative elongation factor 1-delta-like protein; | |
| Q9Y2E8 (SL9A8_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Sodium/hydrogen exchanger 8; Na(+)/H(+) exchanger 8; Solute carrier family 9 member 8; | |
| O95925 (EPPI_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Eppin; Cancer/testis antigen 71; Epididymal protease inhibitor; Protease inhibitor WAP7; Serine protease inhibitor-like with Kunitz and WAP domains 1; WAP four-disulfide core domain protein 7; | |
| Q86VH5 (LRRT3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Leucine-rich repeat transmembrane neuronal protein 3; | |
| Q9NUG6 (PDRG1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | p53 and DNA damage-regulated protein 1; | |
| O14512 (SOCS7_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Suppressor of cytokine signaling 7; Nck, Ash and phospholipase C gamma-binding protein; Nck-associated protein 4; | |
| Q9H2L4 (TMM60_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transmembrane protein 60; | |
| Q9HAA7 (YG046_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein FLJ11871; | |
| Q8N2H3 (PYRD2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2; | |
| O15116 (LSM1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | U6 snRNA-associated Sm-like protein LSm1; Cancer-associated Sm-like; Small nuclear ribonuclear CaSm; | |
| Q2WGJ6 (KLH38_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Kelch-like protein 38; | |
| Q02383 (SEMG2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Semenogelin-2; Semenogelin II; | |
| A6NN90 (CB081_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Uncharacterized protein C2orf81; | |
| P98077 (SHC2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | SHC-transforming protein 2; Protein Sck; SHC-transforming protein B; Src homology 2 domain-containing-transforming protein C2; | |
| Q5BKZ1 (ZN326_HUMAN) | Swiss-Prot | Homo sapiens (Human) | DBIRD complex subunit ZNF326; Zinc finger protein 326; Zinc finger protein interacting with mRNPs and DBC1; | |
| Q9P2U8 (VGLU2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Vesicular glutamate transporter 2; Differentiation-associated BNPI; Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter; Solute carrier family 17 member 6; | |
| Q2M3X9 (ZN674_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 674; | |
| Q96BN6 (F149B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Primary cilium assembly protein FAM149B1; | |
| Q99583 (MNT_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Max-binding protein MNT; Class D basic helix-loop-helix protein 3; Myc antagonist MNT; Protein ROX; | |
| Q92777 (SYN2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Synapsin-2; Synapsin II; | |
| Q9NVN8 (GNL3L_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Guanine nucleotide-binding protein-like 3-like protein; | |
| A2A3L6 (TTC24_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Tetratricopeptide repeat protein 24; | |
| Q86X27 (RGPS2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ras-specific guanine nucleotide-releasing factor RalGPS2; Ral GEF with PH domain and SH3-binding motif 2; RalA exchange factor RalGPS2; | |
| Q8TF68 (ZN384_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 384; CAG repeat protein 1; CAS-interacting zinc finger protein; Nuclear matrix transcription factor 4; Trinucleotide repeat-containing gene 1 protein; | |
| Q8WZ26 (YS006_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein PP6455; | |
| Q6PUV4 (CPLX2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Complexin-2; Complexin II; Synaphin-1; | |
| A8MQ11 (PM2P5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Postmeiotic segregation increased 2-like protein 5; Postmeiotic segregation increased protein 4; Postmeiotic segregation increased protein 7; Putative postmeiotic segregation increased 2 pseudogene 5; | |
| Q6ZNM6 (SMI10_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Sperm-associated microtubule inner protein 10; Testis-expressed protein 43; | |
| Q9NZY2 (FA30A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein FAM30A; | |
| Q16378 (PROL4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Proline-rich protein 4; Lacrimal proline-rich protein; Nasopharyngeal carcinoma-associated proline-rich protein 4; | |
| Q107X0 (KRIP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative protein KRIP1; Kallikrein-related in prostate protein 1; Kallikrein-related mRNA protein; | |
| Q99954 (SMR3A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Submaxillary gland androgen-regulated protein 3A; Proline-rich protein 5; Proline-rich protein PBI; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2024_02 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 20,598 | 17,358 | 42,928 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 25-mer | 26-mer | 32-mer | 34-mer | 36-mer | 39-mer | 40-mer | 44-mer | 46-mer | 48-mer | 55-mer | 56-mer | 60-mer | 62-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38,419 | 3,200 | 302 | 594 | 64 | 118 | 14 | 57 | 3 | 29 | 11 | 38 | 1 | 3 | 22 | 4 | 2 | 1 | 1 | 16 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 1 | 1 | 4 | 2 | 4 | 4 | 2 |